Stryker (SYK) Change in Receivables (2009 - 2026)
Stryker's (SYK) quarterly Change in Receivables came in at $177.0 million in Q2 2026, up 256.64% year-over-year from $49.6 million in Q2 2025, and up 139.86% quarter-over-quarter from -$444.0 million in Q1 2026.
Analysis
Stryker (SYK) Change in Receivables (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Change in Receivables for 18 consecutive years, with $177.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Receivables rose 256.64% year-over-year to $177.0 million in Q2 2026; TTM through Jun 2026 was -$137.0 million, a 182.04% decrease from a year earlier, with the FY2025 full-year figure at -$127.0 million, down 139.56% from the prior year.
- Change in Receivables was $177.0 million for Q2 2026 at Stryker, up from -$444.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $441.0 million in Q4 2023 and troughed at -$444.0 million in Q1 2026.
- A 5-year average of $37.8 million and a median of $39.0 million in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables plunged 841.67% in 2025 and soared 256.64% in 2026, its largest moves.
- Over 5 years, Change in Receivables stood at $393.0 million in 2022, then grew by 12.21% to $441.0 million in 2023, then fell by 12.02% to $388.0 million in 2024, then rose by 2.32% to $397.0 million in 2025, then tumbled by 55.42% to $177.0 million in 2026.
- The last three Change in Receivables figures came in at $177.0 million (Q2 2026), -$444.0 million (Q1 2026), and $397.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 38.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 177.00 Mn |
| Mar 31, 2026 | -444.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Sep 30, 2025 | -267.00 Mn |
| Jun 30, 2025 | -113.00 Mn |
| Mar 31, 2025 | -144.00 Mn |
| Dec 31, 2024 | 388.00 Mn |
| Sep 30, 2024 | 36.00 Mn |
| Jun 30, 2024 | 155.00 Mn |
| Mar 31, 2024 | -258.00 Mn |
| Dec 31, 2023 | 441.00 Mn |
| Sep 30, 2023 | 42.00 Mn |
| Jun 30, 2023 | 57.00 Mn |
| Mar 31, 2023 | -365.00 Mn |
| Dec 31, 2022 | 393.00 Mn |
| Sep 30, 2022 | 27.00 Mn |
| Jun 30, 2022 | 212.00 Mn |
| Mar 31, 2022 | -53.00 Mn |
| Dec 31, 2021 | 232.00 Mn |
| Sep 30, 2021 | 121.00 Mn |